Outcome | Study set | Location | Percentage (%) | P value | OR (95% CI) |
---|---|---|---|---|---|
Success rate | 1st | P vs D | 91.4 (444/486) vs 87.7 (213/243) | 0.11a | 1.49 (0.91–2.45) |
P vs P + D | 91.4 (444/486) vs 86.4 (38/44) | 0.27a | 1.67 (0.67–4.18) | ||
2nd | P vs D | 85.0 (122/142) vs 82.3 (108/131) | 0.52a | 1.28 (0.61–2.67) | |
P vs P + D | 86.7 (104/120) vs 72.2 (13/18) | 0.11a | 2.56 (0.81–8.05) | ||
Severe complication | 1st | P vs D | 10.7 (50/466) vs 30.7 (67/218) | <0.01a | 0.27 (0.18–0.41) |
P vs P + D | 10.7 (50/466) vs 35.6 (16/45) | <0.01a | 0.22 (0.11–0.43) | ||
2nd | P vs D | 18.2 (24/132) vs 28.7 (31/108) | 0.05 | 0.51 (0.26–1.00) | |
P vs P + D | 20.2 (23/114) vs 58.8 (10/17) | 0.00 | 0.10 (0.03–0.36) | ||
DC III | 1st | P vs D | 7.3 (32/438) vs 13.0 (28/216) | 0.02a | 0.53 (0.31–0.90) |
P vs P + D | 7.3 (32/438) vs 10.3 (4/39) | 0.52b | 0.69 (0.23–2.06) | ||
2nd | P vs D | 9.9 (13/131) vs 20.0 (21/105) | 0.07 | 0.49 (0.22–1.06) | |
P vs P + D | 10.8 (10/93) vs 23.1 (3/13) | 0.16 | 0.37 (0.09–1.50) |